Gossamer Bio, Inc.
GOSS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728117
No open-market purchases or sales by Gossamer Bio, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Gossamer Bio, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 141 | 4 | 129 | −8 |
| Shares | 59.9M | 96.9K | 63.7M | +3.91M (+6.5%) |
| Value | $519.8M | $841.0K | $533.2M | +$14.3M (+2.7%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Gossamer Bio, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,053,400 | $8.82M | 0.11% |
| Point72 Asset Management, L.P. | 963,400 | $8.06M | 0.04% |
| Altium Capital Management LP | 260,000 | $2.18M | 0.92% |
| Cinctive Capital Management LP | 103,519 | $866.0K | 0.04% |
| Belvedere Trading LLC | 32,617 | $391.0K | 0.42% |
| Acuta Capital Partners, LLC | 32,000 | $268.0K | 0.15% |
| Mirae Asset Global Investments Co., Ltd. | 19,498 | $163.0K | 0.00% |
| Principal Financial Group Inc | 18,351 | $154.0K | 0.00% |
| E Fund Management Co., Ltd. | 16,419 | $137.0K | 0.01% |
| Delphia (USA) Inc. | 11,935 | $100.0K | 0.07% |
| Corton Capital Inc. | 10,912 | $91.0K | 0.09% |
| Denali Advisors LLC | 9,000 | $75.0K | 0.03% |
| Barclays PLC | 4,979 | $41.0K | 0.00% |
| Walleye Trading LLC | 3,901 | $33.0K | 0.00% |
| Cutler Group LP | 460 | $3.00K | 0.00% |
| Signaturefd, LLC | 212 | $2.00K | 0.00% |
| Howe & Rusling Inc | 100 | $1.00K | 0.00% |
| Venture Visionary Partners LLC | 100 | $837 | 0.00% |
Sold out (26)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (4)
Institutions that held Gossamer Bio, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Virginia Retirement Systems Et Al | 43,000 | $373.0K |
| Parametric Portfolio Associates LLC | 29,249 | $254.0K |
| Susquehanna Fundamental Investments, LLC | 17,141 | $149.0K |
| Amalgamated Financial Corp. | 7,486 | $65.0K |